E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 11 230 KRW -1.32% Market Closed
Market Cap: 411.6B KRW

Operating Margin
EuBiologics Co Ltd

41.4%
Current
9%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
41.4%
=
Operating Profit
63.7B
/
Revenue
153.7B

Operating Margin Across Competitors

No Stocks Found

EuBiologics Co Ltd
Glance View

Market Cap
411.3B KRW
Industry
Biotechnology

EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 323 full-time employees. The company went IPO on 2017-01-24. The firm operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.

Intrinsic Value
19 135 KRW
Undervaluation 41%
Intrinsic Value
Price
E
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
41.4%
=
Operating Profit
63.7B
/
Revenue
153.7B
What is the Operating Margin of EuBiologics Co Ltd?

Based on EuBiologics Co Ltd's most recent financial statements, the company has Operating Margin of 41.4%.

Back to Top